PAVMED INC (PAVM)
US70387R4039 - Common Stock
Taking everything into account, PAVM scores 2 out of 10 in our fundamental rating. PAVM was compared to 187 industry peers in the Health Care Equipment & Supplies industry. PAVM has a bad profitability rating. Also its financial health evaluation is rather negative. PAVM is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PAVM had negative earnings in the past year.
PAVM had a negative operating cash flow in the past year.
In the past 5 years PAVM always reported negative net income.
PAVM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
PAVM's Return On Assets of 48.17% is amongst the best of the industry. PAVM outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 48.17% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-141.22%
ROA(5y)-165.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PAVM (364.77%) is better than 99.47% of its industry peers.
PAVM does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 364.77% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PAVM has been reduced compared to 1 year ago.
The number of shares outstanding for PAVM has been reduced compared to 5 years ago.
Compared to 1 year ago, PAVM has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -18.90, we must say that PAVM is in the distress zone and has some risk of bankruptcy.
PAVM has a Altman-Z score of -18.90. This is amonst the worse of the industry: PAVM underperforms 87.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -18.9 |
ROIC/WACCN/A
WACC5.84%
2.3 Liquidity
PAVM has a Current Ratio of 0.06. This is a bad value and indicates that PAVM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.06, PAVM is not doing good in the industry: 98.40% of the companies in the same industry are doing better.
A Quick Ratio of 0.06 indicates that PAVM may have some problems paying its short term obligations.
PAVM's Quick ratio of 0.06 is on the low side compared to the rest of the industry. PAVM is outperformed by 98.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.06 | ||
| Quick Ratio | 0.06 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 61.30% over the past year.
The Revenue has grown by 165.39% in the past year. This is a very strong growth!
EPS 1Y (TTM)61.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)165.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%25.92%
3.2 Future
Based on estimates for the next years, PAVM will show a very strong growth in Earnings Per Share. The EPS will grow by 24.80% on average per year.
The Revenue is expected to grow by 149.88% on average over the next years. This is a very strong growth
EPS Next Y34.52%
EPS Next 2Y35.57%
EPS Next 3Y24.8%
EPS Next 5YN/A
Revenue Next Year50.08%
Revenue Next 2Y128.81%
Revenue Next 3Y175.66%
Revenue Next 5Y149.88%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
PAVM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PAVM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as PAVM's earnings are expected to grow with 24.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.57%
EPS Next 3Y24.8%
5. Dividend
5.1 Amount
PAVM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PAVMED INC
NASDAQ:PAVM (12/24/2024, 7:30:31 PM)
After market: 0.688 +0.03 (+4.86%)0.6561
+0.01 (+1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners13.83%
Inst Owner Change-66.98%
Ins Owners7.52%
Ins Owner Change0%
Market Cap7.26M
Analysts80
Price Target9.86 (1402.82%)
Short Float %2.94%
Short Ratio4.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.4%
Min EPS beat(2)-28.52%
Max EPS beat(2)19.72%
EPS beat(4)2
Avg EPS beat(4)-14.05%
Min EPS beat(4)-53.5%
Max EPS beat(4)19.72%
EPS beat(8)5
Avg EPS beat(8)-2.79%
EPS beat(12)5
Avg EPS beat(12)-7.04%
EPS beat(16)5
Avg EPS beat(16)-11.98%
Revenue beat(2)0
Avg Revenue beat(2)-15.47%
Min Revenue beat(2)-20.28%
Max Revenue beat(2)-10.67%
Revenue beat(4)0
Avg Revenue beat(4)-9.69%
Min Revenue beat(4)-20.28%
Max Revenue beat(4)-1.87%
Revenue beat(8)2
Avg Revenue beat(8)-17.67%
Revenue beat(12)2
Avg Revenue beat(12)-33.14%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.33%
EPS NQ rev (1m)9.52%
EPS NQ rev (3m)55.12%
EPS NY rev (1m)0%
EPS NY rev (3m)0.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-51.29%
Revenue NY rev (1m)-10.48%
Revenue NY rev (3m)-22.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.8 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-4.18
EYN/A
EPS(NY)-1.48
Fwd EYN/A
FCF(TTM)-4.13
FCFYN/A
OCF(TTM)-4.11
OCFYN/A
SpS0.36
BVpS-0.44
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 48.17% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 364.77% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-141.22%
ROA(5y)-165.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 12.59% | ||
| Cap/Sales | 5.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.06 | ||
| Quick Ratio | 0.06 | ||
| Altman-Z | -18.9 |
F-Score5
WACC5.84%
ROIC/WACCN/A
Cap/Depr(3y)236.66%
Cap/Depr(5y)262%
Cap/Sales(3y)236.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next Y34.52%
EPS Next 2Y35.57%
EPS Next 3Y24.8%
EPS Next 5YN/A
Revenue 1Y (TTM)165.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%25.92%
Revenue Next Year50.08%
Revenue Next 2Y128.81%
Revenue Next 3Y175.66%
Revenue Next 5Y149.88%
EBIT growth 1Y27.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.83%
OCF growth 3YN/A
OCF growth 5YN/A